Treatment for Rare Skin Disease
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
20
NCT05211830
A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 7, 2021
Completion: Dec 20, 2022
Loading map...